AI Terminal
Convatec Group PLC
Transaction in Own Shares • Mar 18, 2025
4959_dirs_2025-03-18_225de8f1-8169-4668-bebc-ef84c94d2646.html
Transaction in Own Shares
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 1902B
Convatec Group PLC
18 March 2025
18 March 2025
Convatec Group Plc
("Convatec" or "the Company")
Director/ PDMR Shareholding
The Company has been notified of the following transactions in relation to Persons Discharging Managerial Responsibility ("PDMR") in respect of ordinary shares of 10 pence each in the Company ("Shares").
1. Vesting of Awards under the Company's Long Term Incentive Plan ("LTIP")
On 14 March 2025, conditional share awards granted to Karim Bitar, Chief Executive Officer under the LTIP in the form of Performance Share Awards ("PSA") vested and on 17 March 2025, shares were sold to satisfy income tax and National Insurance ("NI") liabilities:
| Shares vested | Shares sold to satisfy income tax & NI liabilities | Share price | Total shares acquired |
| 926,575 | 436,692 | £2.561244 | 489,883 |
2. Vesting of Awards under the Company's Deferred Bonus Plan ("DBP")
On 14 March 2025 , awards granted to Karim Bitar in 2022, under the DBP in the form of Restricted Stock Units ("RSU") also vested and on 17 March 2025, shares were sold to satisfy income tax and NI liabilities:
| Shares vested | Shares sold to satisfy income tax & NI liabilities | Share price | Total shares acquired |
| 280,615 | 132,253 | £2.561244 | 148,362 |
1. Vesting of Awards under the Company's LTIP
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Karim Bitar
2
Reason for the notification
a)
Position/status
Chief Executive Officer and PDMR
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Convatec Group Plc
b)
LEI
213800LS272L4FIDOH92
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary share of 10p each in Convatec Group Plc
Identification code
GB00BD3VFW73
b)
Nature of the transaction
Vesting of PSA under the LTIP.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £0 | 926,575 |
d)
Aggregated information
- Aggregated volume
N/A - single transaction
- Price
e)
Date of the transaction
14 March 2025
f)
Place of the transaction
Outside a trading venue
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary share of 10p each in Convatec Group Plc
Identification code
GB00BD3VFW73
b)
Nature of the transaction
Immediate sale of shares awarded under the LTIP to cover tax and national insurance liabilities.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £2.561244 | 436,692 |
d)
Aggregated information
- Aggregated volume
N/A - single transaction
- Price
e)
Date of the transaction
17 March 2025
f)
Place of the transaction
London Stock Exchange
2. Vesting of Awards under the Company's DBP
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Karim Bitar
2
Reason for the notification
a)
Position/status
Chief Executive Officer and PDMR
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Convatec Group Plc
b)
LEI
213800LS272L4FIDOH92
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary share of 10p each in Convatec Group Plc
Identification code
GB00BD3VFW73
b)
Nature of the transaction
Vesting of RSU under the DBP.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £0 | 280,615 |
d)
Aggregated information
- Aggregated volume
N/A - single transaction
- Price
e)
Date of the transaction
14 March 2025
f)
Place of the transaction
Outside a trading venue
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary share of 10p each in Convatec Group Plc
Identification code
GB00BD3VFW73
b)
Nature of the transaction
Immediate sale of shares awarded under the DBP to cover tax and national insurance liabilities.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £2.561244 | 132,253 |
d)
Aggregated information
- Aggregated volume
N/A - single transaction
- Price
e)
Date of the transaction
17 March 2025
f)
Place of the transaction
London Stock Exchange
Enquiries
James Kerton Company Secretary
Tel: +44 (7827) 036059
Email: [email protected]
Convatec Group Plc's LEI code is 213800LS272L4FIDOH92
Classification: 2.2 Information disclosed under article 19 of the Market Abuse Regulation
About Convatec
Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With more than 10,000 colleagues, we provide our products and services in around 90 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. Convatec's revenues in 2024 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more please visit http://www.convatecgroup.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFLFVDVIITLIE